Medicare Advantage Risk Deals in 2025 & Beyond: Significant Changes, Increase Risks, & How to Manage Them
Arbital Health
Nov 19, 2024
Speakers:
- Jesica Freeman | Chief Product | OfficerArbital Health
- Rich Gamret, FSA, MAAA | Chief Delivery Officer | Arbital Health
- Lewis Mattison| Managing Director & Founder | Mattison Advisory
- Andrew Mackenzie, FSA, CERA, MAAA | Chief Science Officer | Arbital Health
About the Discussion
As Medicare Advantage plans face significant headwinds—including rising trends, transformative changes in the HCC landscape, the far-reaching effects of the Inflation Reduction Act, and widespread contractual and settlement issues—it's essential for all value-based care (VBC) stakeholders to stay informed. Our analysis has identified key trends across the industry likely to impact financial settlements in 2025 and 2026.
Our expert panelists covered:
- 2024 Rising Healthcare Claims Costs
- Inflation Reduction Act Impact on Part D Plans
- HCC Model Changes Explained
- CMS Star Ratings Updates
If you are involved in any aspect of Medicare Advantage risk-based contracting, this discussion is an opportunity you won’t want to miss!
